Enovis Corporation ENOV

Set alert

Price alert · ENOV

All alert types
20.62 USD +0.71 +3.57%

At close · Nov 2

20.62 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
20.56 × 700
Ask
20.81 × 600
20.41 Day range 21.66
16.70 52-week range 32.41
YTD
-22.60%
1 year
-33.99%
Open
20.37
Prev close
19.91
Mkt cap
1.19B
Vol
2.49M
Avg vol
1.57M
EPS
-19.92
P/E
0.00
Div yield
0.00%
More statistics
Low
20.41
High
21.66
Forward P/E
5.87
Beta
1.42
Short ratio
7.14
Inst. own
119.20%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
20.01
200-d avg
23.07
1y target
36.08

2Y chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: 0.79; estimate 0.74; surprise 6.76%
  • Nov 6, 2025Earnings: 0.75; estimate 0.67; surprise 11.94%
  • Feb 26, 2026Earnings: 0.95; estimate 0.81; surprise 17.28%
  • May 7, 2026Earnings: 0.89; estimate 0.82; surprise 8.54%
  • Aug 6, 2026Earnings: 0.9; estimate 0.847; surprise 6.26%
  • Aug 17, 2026Rating: Canaccord Genuity · Buy → Buy
  • Sep 1, 2026Rating: BTIG · Buy → Buy
  • Sep 2, 2026Rating: Freedom Capital Markets · Buy → Buy
  • Sep 2, 2026Rating: Citizens · Market Outperform → Market Outperform
  • Sep 2, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 12, 2026Rating: Needham · Buy → Buy
Signals (96)
NameDateAgo
SMA: BullishNov 2, 202620 hours ago
SMA: BearishOct 30, 20263 days ago
RSI: OverboughtOct 29, 20264 days ago
SMA: BullishOct 20, 20261 week ago
MACD: Buy SignalSep 23, 20261 month ago
RSI: OversoldSep 10, 20261 month ago
RSI: OversoldSep 2, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BearishAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BearishAug 10, 20262 months ago
MACD: Sell SignalAug 6, 20262 months ago

Newest 20 of 96.

Key statistics

Market cap
1.20B
Enterprise value
2.51B
Trailing P/E
0.00
Forward P/E
5.87
PEG ratio
3.45
Price / sales
0.52
Price / book
0.81
EPS (TTM)
-19.23
Beta
1.42
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-47.97%
Revenue (TTM)
2.30B
Revenue growth
3.20%
Free cash flow
185.94M
Total cash
12.56M
Total debt
1.37B
Return on equity
-54.14%
Shares outstanding
57.67M
Short % of float
24.18%
50-day average
20.01
200-day average
23.07

Financials — quick view

All financials
ENOV Revenue — quarterly 582.78M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ENOV Net income — quarterly -1.19M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ENOV EPS — quarterly -0.02
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ENOV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Oct 3, 20260.767———
Aug 6, 2026Jul 3, 20260.8470.90+0.05+6.26%
May 7, 2026Apr 3, 20260.820.89+0.07+8.54%
Feb 26, 2026Dec 31, 20250.810.95+0.14+17.28%
Nov 6, 2025Oct 3, 20250.670.75+0.08+11.94%
Aug 7, 2025Jul 4, 20250.740.79+0.05+6.76%

Upgrades / downgrades

ENOV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026NeedhammainBuyBuy
Sep 2, 2026Wells FargomainOverweightOverweight
Sep 2, 2026CitizensmainMarket OutperformMarket Outperform
Sep 2, 2026Freedom Capital MarketsmainBuyBuy
Sep 1, 2026BTIGmainBuyBuy
Aug 17, 2026Canaccord GenuitymainBuyBuy

About Enovis Corporation

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
enovis.com

News

Your note

Sign in to keep a note on ENOV — it syncs with the Stock Master app.

Insider holders

ENOV insider holders
InsiderRelationLatest transactionDateShares held
BERRY PHILLIP BENJAMIN BENChief Financial OfficerStock Award(Grant)Mar 8, 2026158,596
ENGERT OLIVEROfficerPurchaseSep 3, 202663,898
LANG PATRICIA AOfficerStock Award(Grant)Mar 8, 202675,703
MCDONALD DAMIENChief Executive OfficerPurchaseSep 3, 2026247,077
PRYOR DANIEL ALEXISFormerSaleDec 8, 20250
ROSS TERRY DOfficerStock Award(Grant)Mar 8, 202668,477

Institution ownership

ENOV institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.85%10,295,666214.25MJun 29, 2026
American Century Companies Inc10.59%6,106,561127.08MJun 29, 2026
Vanguard Portfolio Management LLC6.81%3,926,26881.71MJun 29, 2026
Rubric Capital Management LP6.76%3,900,00081.16MJun 29, 2026
Vanguard Capital Management LLC4.31%2,484,31851.70MJun 29, 2026
State Street Corporation4.27%2,462,78851.25MJun 29, 2026

Fund ownership

ENOV fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%3,431,56971.41MSep 29, 2026
American Century Capital Portfolios, Inc.-Small Cap Value Fund4.54%2,620,00054.52MJun 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Value Fund4.04%2,328,36048.45MJul 30, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF3.80%2,189,18245.56MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.98%1,719,53035.78MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%1,493,64331.08MSep 29, 2026